Trial · NCT03470922
Adverse events556
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 556
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Arm A: Relatlimab + Nivolumab | 50 | 355 | |
| other | Anaemia | Blood and lymphatic system disorders | Arm B: Nivolumab | 37 | 359 | |
| other | Hyperthyroidism | Endocrine disorders | Arm A: Relatlimab + Nivolumab | 23 | 355 | |
| other | Hyperthyroidism | Endocrine disorders | Arm B: Nivolumab | 28 | 359 | |
| other | Hypothyroidism | Endocrine disorders | Arm A: Relatlimab + Nivolumab | 58 | 355 | |
| other | Hypothyroidism | Endocrine disorders | Arm B: Nivolumab | 47 | 359 | |
| other | Abdominal pain | Gastrointestinal disorders | Arm A: Relatlimab + Nivolumab | 31 | 355 | |
| other | Abdominal pain | Gastrointestinal disorders | Arm B: Nivolumab | 31 | 359 | |
| other | Constipation | Gastrointestinal disorders | Arm A: Relatlimab + Nivolumab | 39 | 355 | |
| other | Constipation | Gastrointestinal disorders | Arm B: Nivolumab | 25 | 359 | |
| other | Diarrhoea | Gastrointestinal disorders | Arm A: Relatlimab + Nivolumab | 82 | 355 | |
| other | Diarrhoea | Gastrointestinal disorders | Arm B: Nivolumab | 62 | 359 | |
| other | Dry mouth | Gastrointestinal disorders | Arm A: Relatlimab + Nivolumab | 28 | 355 | |
| other | Dry mouth | Gastrointestinal disorders | Arm B: Nivolumab | 18 | 359 | |
| other | Nausea | Gastrointestinal disorders | Arm A: Relatlimab + Nivolumab | 63 | 355 | |
| other | Nausea | Gastrointestinal disorders | Arm B: Nivolumab | 59 | 359 | |
| other | Vomiting | Gastrointestinal disorders | Arm A: Relatlimab + Nivolumab | 33 | 355 | |
| other | Vomiting | Gastrointestinal disorders | Arm B: Nivolumab | 20 | 359 | |
| other | Asthenia | General disorders | Arm A: Relatlimab + Nivolumab | 48 | 355 | |
| other | Asthenia | General disorders | Arm B: Nivolumab | 33 | 359 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03470922/events